Mycophenolate-update after it has come of age.
作者信息
Grinyó J M
出版信息
Nephrol Dial Transplant. 1999 Jan;14(1):31-4. doi: 10.1093/ndt/14.1.31.
PMID:10052471
Abstract
摘要
相似文献
1
Mycophenolate-update after it has come of age.
Nephrol Dial Transplant. 1999 Jan;14(1):31-4. doi: 10.1093/ndt/14.1.31.
2
Mycophenolate mofetil for prevention of acute rejection.
Lancet. 1995 Jul 22;346(8969):253-4.
3
Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group.
Transplant Proc. 1998 Jun;30(4):1297-8. doi: 10.1016/s0041-1345(98)00249-8.
4
Mycophenolate mofetil reduces graft loss due to chronic allograft nephropaty.
Transplant Proc. 2002 Mar;34(2):567-8. doi: 10.1016/s0041-1345(02)02622-2.
5
The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).
Transplantation. 1994 Feb 27;57(4):640-3.
6
Cytokine analysis before and after mycophenolate mofetil treatment in renal transplantation.
Transplant Proc. 2000 Dec;32(8):2631-2. doi: 10.1016/s0041-1345(00)01812-1.
7
Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.
Transpl Int. 2005 Nov;18(11):1286-91. doi: 10.1111/j.1432-2277.2005.00205.x.
8
Reversal of acute allograft rejection using immunotoxin.
Transplant Proc. 1998 Aug;30(5):2150-1. doi: 10.1016/s0041-1345(98)00569-7.
9
Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
Drugs. 1996 Feb;51(2):278-98. doi: 10.2165/00003495-199651020-00007.
10
Questionable long-term benefit of mycophenolate.
Transplantation. 2000 Jul 27;70(2):401. doi: 10.1097/00007890-200007270-00032.
引用本文的文献
1
Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.
Pharmacoeconomics. 2002;20(10):675-713. doi: 10.2165/00019053-200220100-00004.
2
Immunosuppression in older renal transplant patients.
Drugs Aging. 2000 Apr;16(4):279-87. doi: 10.2165/00002512-200016040-00004.
Zotero 插件